CL2022000590A1 - Métodos para mejorar la fusión vertebral con abaloparatida - Google Patents

Métodos para mejorar la fusión vertebral con abaloparatida

Info

Publication number
CL2022000590A1
CL2022000590A1 CL2022000590A CL2022000590A CL2022000590A1 CL 2022000590 A1 CL2022000590 A1 CL 2022000590A1 CL 2022000590 A CL2022000590 A CL 2022000590A CL 2022000590 A CL2022000590 A CL 2022000590A CL 2022000590 A1 CL2022000590 A1 CL 2022000590A1
Authority
CL
Chile
Prior art keywords
abaloparatide
methods
spinal fusion
vertebral
subject
Prior art date
Application number
CL2022000590A
Other languages
English (en)
Inventor
Beate Klara Maria Mannstadt
Bruce Mitlak
Original Assignee
Radius Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radius Health Inc filed Critical Radius Health Inc
Publication of CL2022000590A1 publication Critical patent/CL2022000590A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4601Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente se proveen métodos para mejorar la fusión vertebral y la formación del hueso en sujetos con fracturas vertebrales, deformidades o inestabilidad en la columna vertebral. Los métodos incluyen administrar al sujeto (por ejemplo, por vía subcutánea o transdérmica) una cantidad terapéuticamente eficaz de abaloparatida. En un aspecto, en la presente se provee un método para mejorar la fusión vertebral, que incluye administrar una cantidad terapéuticamente eficaz de abaloparatida a un sujeto con una fractura vertebral, de manera de mejorar la fusión vertebral en el sujeto.
CL2022000590A 2019-09-12 2022-03-10 Métodos para mejorar la fusión vertebral con abaloparatida CL2022000590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962899633P 2019-09-12 2019-09-12

Publications (1)

Publication Number Publication Date
CL2022000590A1 true CL2022000590A1 (es) 2022-11-11

Family

ID=74866536

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2022000590A CL2022000590A1 (es) 2019-09-12 2022-03-10 Métodos para mejorar la fusión vertebral con abaloparatida
CL2023001017A CL2023001017A1 (es) 2019-09-12 2023-04-06 Métodos para mejorar la fusión vertebral con abaloparatida

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2023001017A CL2023001017A1 (es) 2019-09-12 2023-04-06 Métodos para mejorar la fusión vertebral con abaloparatida

Country Status (7)

Country Link
US (1) US20220193203A1 (es)
EP (1) EP4027899A4 (es)
CN (1) CN114364327A (es)
BR (1) BR112022004462A2 (es)
CL (2) CL2022000590A1 (es)
MX (1) MX2022002979A (es)
WO (1) WO2021051082A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1005359B1 (en) * 1997-09-09 2005-06-15 F. Hoffmann-La Roche Ag FRACTURE HEALING USING PTHrP ANALOGS
WO2005038453A1 (en) * 2003-10-17 2005-04-28 Medvet Science Pty Ltd Early assessment of motor recovery in spinal cord injury patients
ES2927067T3 (es) * 2015-03-03 2022-11-02 Radius Health Inc Abaloparatida combinada con alendronato para la reducción de las fracturas óseas no vertebrales
PL3359241T3 (pl) * 2015-10-09 2021-12-20 Radius Health, Inc. Formulacje analogów pthrp, plastry przezskórne je zawierające i ich zastosowania

Also Published As

Publication number Publication date
WO2021051082A1 (en) 2021-03-18
BR112022004462A2 (pt) 2022-05-31
EP4027899A1 (en) 2022-07-20
CN114364327A (zh) 2022-04-15
EP4027899A4 (en) 2023-08-16
MX2022002979A (es) 2022-06-16
CL2023001017A1 (es) 2023-12-11
US20220193203A1 (en) 2022-06-23

Similar Documents

Publication Publication Date Title
Blomstedt Orthopedic surgery in ancient Egypt
IN2015DN01568A (es)
EA202190569A1 (ru) Способы лечения болезни фабри у пациентов, имеющих мутацию в гене gla
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
BR112013001946A2 (pt) vírus varicela zoster inativado, composição farmacêutica, método para preparar um vírus varicela zoster inativado, vacina, e, método para o tratamento de herpes zoster em um indivíduo
CL2022000590A1 (es) Métodos para mejorar la fusión vertebral con abaloparatida
RU126260U1 (ru) Пластина для остеосинтеза при множественных флотирующих переломах ребер
RU2547784C1 (ru) Способ фиксации васкуляризированного надкостнично-кортикального трансплантата
RU2013126506A (ru) Способ лечения перелома межмыщелкового возвышения большеберцовой кости
CL2020000479A1 (es) Métodos para el tratamiento de enfermedades relacionadas con tnfa.
Afsar et al. Pain lowering effect of hematoma block for close reduction of distal radius fractures
CO2020001314A2 (es) Tratamiento de pacientes con enfermedad de von willebrand grave que se someten a cirugía electiva mediante administración de vwf recombinante
MX2021016043A (es) Formulacion de doxorrubicina liposomal, metodo para producir una formulacion de doxorrubicina liposomal y uso de una formulacion de doxorrubicina liposomal como un medicamento.
Shimbaretskiy LEADING ROLE OF KINEZOTHERAPY IN REHABILITATION OF PATIENTS AFTER OSTEOSYNTHESIS WITH APPLICATION OF MODERN CONSTRUCTIONS
BR112016006145A2 (pt) dispositivo de fixação externa para osteossíntese do ombro
RU2618082C1 (ru) Способ хирургического лечения осложненной варусной деформации локтевого сустава с надмыщелковым синдромом
UA126272U (uk) Спосіб малоінвазивного оперативного лікування переломів
RU2546538C1 (ru) Способ лечения дегенеративно-дистрофических, воспалительно-дегенеративных заболеваний и травматических повреждений мягких тканей опорно-двигательного аппарата
de Lima Martins et al. Why cluster headache is also called" suicide headache"?
CL2023001783A1 (es) Métodos para el tratamiento de la acondroplasia
UA125128U (uk) Спосіб малоінвазивного остеосинтезу переломів п'яткової кістки
Daia et al. Towards a new indication for extracorporeal shock wave therapy: Idiopathic scoliosis
Ding et al. Treatment timing for kyphoplasty with bone cement injection in patients with thoracolumbar vertebral compression fractures
UA88435U (ru) Способ оперативного лечения полифрагментарных переломов проксимального отдела плечевой кости
RU2011123353A (ru) Способ лечения переломов проксимального отдела бедренной кости